ClinicalTrials.Veeva

Menu

Effect of Tulsi (Ocimum Sanctum) on Biochemical Parameters in Young Overweight and Obese Subjects

A

All India Institute of Medical Sciences, Bhubaneswar

Status and phase

Completed
Phase 2

Conditions

Obesity

Treatments

Drug: Tulsi(Ocimum sanctum Linn.) capsules

Study type

Interventional

Funder types

Other

Identifiers

NCT02681939
T/IM-NF/Physio/15/04

Details and patient eligibility

About

This is a study to investigate the effect of Tulsi (Ocimum sanctum Linn.) on metabolic and biochemical parameters in young overweight and obese subjects. Thirty overweight/obese volunteers will be divided into two groups. The first group will receive no intervention. The second group will be supplemented with one capsule of Tulsi orally every morning and evening in empty stomach for 60 days. The metabolic parameters and liver enzymes will be evaluated before and after the intervention.

Full description

This is a randomized, parallel group, open label pilot study to investigate the effect of Tulsi (Ocimum sanctum Linn.) on metabolic and biochemical parameters in young overweight and obese subjects. Thirty overweight/obese volunteers will be divided into two groups. The first group will receive no intervention. The second group will be supplemented with one capsule of Tulsi orally every morning and evening in empty stomach for 60 days. The metabolic parameters and liver enzymes will be evaluated before and after the intervention.

Enrollment

30 patients

Sex

All

Ages

17 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Overweight/obese volunteers of both genders from age 17 to 30 years

Exclusion criteria

  • Addiction to tobacco and/or alcohol.
  • Not on drugs like fluoroquinolones, anticonvulsants, antihypertensives, corticosteroids, hormonal contraceptives, hypolipidemic agents, anti psychotics, protease inhibitors and isotretinoin.
  • Not suffering from liver disease, malabsorption, nephrotic syndrome, thyroid disorder, allergy or any other chronic disease.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Tulsi
Experimental group
Description:
One capsule of Tulsi (Ocimum sanctum) orally, every morning and evening in empty stomach for 60 days regularly.
Treatment:
Drug: Tulsi(Ocimum sanctum Linn.) capsules
No Tulsi
No Intervention group
Description:
No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems